Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here. 		You are subscribed to Ophthalmology Times Europe.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
• Coats' disease and bevacizumab
• Clobetasone butyrate for SS
• Aflibercept improves VA
• A-P method and IOL power
 
 
Survey

Would you use Indocyanine green (ICG) enhanced transpupillary thermotherapy (TTT) in combination with ophthalmic artery chemosurgery to treat retinoblastoma?

Yes
75%
No
25%

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.
February 27, 2013
Coats' disease treated with bevacizumab
Bevacizumab could play a role in treating Coats' disease, claims a recent study. More...
Clobetasone butyrate safe and effective for SS
Low doses of clobetasone butyrate drops are safe and effective for Sjögren syndrome (SS). More...
Aflibercept injections improves VA in CRVO patients
Monthly intravitreal aflibercept significantly improves visual acuity (VA) in patients with macular oedema secondary to central retinal vein occlusion (CRVO), according to the latest phase of the COPERNICUS study. More...
A-P method may calculate IOL power
The anterior-posterior (A-P) method is effective for calculating IOL power when preoperative LASIK data is unavailable. More...